U.S., Jan. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07352254) titled 'OutreAch MediCal Care for HousEbound Patients With Post-COVID Syndrome or ME/CFS of Any Cause (ACCESS)' on Jan. 11.
Brief Summary: The significance of the Post-COVID Syndrome (PCS) has been widely acknowledged. Various efforts are made to find out about the pathomechanisms behind PCS and to establish therapies. One sub-group of PCS-patients, however, is generally excluded from any studies, and that are those who are unable to visit outpatient clinics or hospitals for diagnostic work up or participation in clinical trials, as they are unable to leave their home and to seek medical support on their own physical and mental capabilities...